Product Name

  • Name

    Cefoxitin

  • EINECS 252-641-2
  • CAS No. 35607-66-0
  • Article Data12
  • CAS DataBase
  • Density 1.63 g/cm3
  • Solubility Predicted solubility in water is less than 0.2mg/ml
  • Melting Point 149 - 150oC
  • Formula C16H17N3O7S2
  • Boiling Point 843.4 °C at 760 mmHg
  • Molecular Weight 427.459
  • Flash Point 463.9 °C
  • Transport Information UN 3077
  • Appearance White to off-white crystalline powder
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 35607-66-0 (Cefoxitin)
  • Hazard Symbols
  • Synonyms 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-,(6R,7S)- (9CI);5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-,(6R-cis)-;Cephoxitin;
  • PSA 201.80000
  • LogP 1.12770

Synthetic route

desacetyl cephalosporin C
1476-46-6

desacetyl cephalosporin C

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Stage #1: desacetyl cephalosporin C With N,N'-dibenzylethylenediamine diacetate In dichloromethane; water at 25℃;
Stage #2: With isocyanate de chlorosulfonyle In dichloromethane at -40℃; Temperature; Further stages;
96%
isocyanate de chlorosulfonyle
1189-71-5

isocyanate de chlorosulfonyle

2C15H16N2O6S2*C16H20N2

2C15H16N2O6S2*C16H20N2

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
In acetone at -35 - -30℃;82.8%
isocyanate de chlorosulfonyle
1189-71-5

isocyanate de chlorosulfonyle

3-hydroxymethyl-7α-[(2-thienyl)acetamido]-4-cephalosporanic acid benzathine salt

3-hydroxymethyl-7α-[(2-thienyl)acetamido]-4-cephalosporanic acid benzathine salt

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Stage #1: isocyanate de chlorosulfonyle; 3-hydroxymethyl-7α-[(2-thienyl)acetamido]-4-cephalosporanic acid benzathine salt In acetone at -50 - -45℃; for 2h;
Stage #2: With water In acetone at 8 - 10℃;
65%
In tetrahydrofuran Cooling;
Stage #1: isocyanate de chlorosulfonyle; 3-hydroxymethyl-7α-[(2-thienyl)acetamido]-4-cephalosporanic acid benzathine salt In tetrahydrofuran at -50 - -45℃; for 1h;
Stage #2: With water In tetrahydrofuran at 10 - 12℃; for 0.5h;
Stage #3: With hydrogenchloride In water at 0 - 34℃; for 1.5h; pH=1.9 - 2.1; Solvent; Temperature;
diphenylmethyl (6R, 7S)-7-(2'-thienyl)acetamido-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-carboxylate
35607-68-2

diphenylmethyl (6R, 7S)-7-(2'-thienyl)acetamido-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-carboxylate

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
With trifluoroacetic acid In various solvent(s) 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min;56%
2-thienylacetic acid chloride
39098-97-0

2-thienylacetic acid chloride

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
2: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
cephamycin C
32178-84-0

cephamycin C

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) N-trichloroethoxycarbonylation, 2.) benzhydryl esterification
2: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
3: 1.) PhN=C=NPh, 2.) N,N-dimethylaniline / 1.) CH2Cl2, 18 h, 0 deg C, 2.) CH2Cl2
4: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 5 steps
1: 1.) N-trichloroethoxycarbonylation, 2.) benzhydryl esterification
2: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
3: 87 percent / H2O, conc. HCl / acetone / 72 h / Ambient temperature
4: 1.) PhN=C=NPh, 2.) N,N-dimethylaniline / 1.) CH2Cl2, 18 h, 0 deg C, 2.) CH2Cl2
5: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 6 steps
1: 1.) N-trichloroethoxycarbonylation, 2.) benzhydryl esterification
2: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
3: 87 percent / H2O, conc. HCl / acetone / 72 h / Ambient temperature
4: 56 percent / diphenylcarbodiimide / CH2Cl2 / 18 h / 0 °C
5: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
6: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 5 steps
1: 1.) N-trichloroethoxycarbonylation, 2.) benzhydryl esterification
2: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
3: 56 percent / diphenylcarbodiimide / CH2Cl2 / 18 h / 0 °C
4: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
5: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
(6R)-7t-[(R)-5-benzhydryloxycarbonyl-5-(2,2,2-trichloro-ethoxycarbonylamino)-pentanoylamino]-3-carbamoyloxymethyl-7c-methoxy-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester
35664-28-9

(6R)-7t-[(R)-5-benzhydryloxycarbonyl-5-(2,2,2-trichloro-ethoxycarbonylamino)-pentanoylamino]-3-carbamoyloxymethyl-7c-methoxy-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
2: 1.) PhN=C=NPh, 2.) N,N-dimethylaniline / 1.) CH2Cl2, 18 h, 0 deg C, 2.) CH2Cl2
3: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 4 steps
1: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
2: 87 percent / H2O, conc. HCl / acetone / 72 h / Ambient temperature
3: 1.) PhN=C=NPh, 2.) N,N-dimethylaniline / 1.) CH2Cl2, 18 h, 0 deg C, 2.) CH2Cl2
4: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 5 steps
1: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
2: 87 percent / H2O, conc. HCl / acetone / 72 h / Ambient temperature
3: 56 percent / diphenylcarbodiimide / CH2Cl2 / 18 h / 0 °C
4: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
5: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 4 steps
1: 1.) Na2CO3, 2.) H2O / 1.) dioxane, 5 deg C, then 20 deg C, 12 h, 2.) 1 h
2: 56 percent / diphenylcarbodiimide / CH2Cl2 / 18 h / 0 °C
3: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
4: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
diphenylmethyl (6R, 7S)-7-amino-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-carboxylate
52390-38-2

diphenylmethyl (6R, 7S)-7-amino-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-carboxylate

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
2: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
diphenylmethyl (6R,7S)-7-carboxycarbonylamino-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-carboxylate
66893-40-1

diphenylmethyl (6R,7S)-7-carboxycarbonylamino-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-carboxylate

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) PhN=C=NPh, 2.) N,N-dimethylaniline / 1.) CH2Cl2, 18 h, 0 deg C, 2.) CH2Cl2
2: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 3 steps
1: 56 percent / diphenylcarbodiimide / CH2Cl2 / 18 h / 0 °C
2: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
3: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
(6R)-7t-hydroxyoxalylamino-3-(hydroxyoxalylcarbamoyloxy-methyl)-7c-methoxy-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester
68318-53-6

(6R)-7t-hydroxyoxalylamino-3-(hydroxyoxalylcarbamoyloxy-methyl)-7c-methoxy-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester

cefoxitin
35607-66-0

cefoxitin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 87 percent / H2O, conc. HCl / acetone / 72 h / Ambient temperature
2: 1.) PhN=C=NPh, 2.) N,N-dimethylaniline / 1.) CH2Cl2, 18 h, 0 deg C, 2.) CH2Cl2
3: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme
Multi-step reaction with 4 steps
1: 87 percent / H2O, conc. HCl / acetone / 72 h / Ambient temperature
2: 56 percent / diphenylcarbodiimide / CH2Cl2 / 18 h / 0 °C
3: 61 percent / N,N-dimethylaniline / CH2Cl2 / 15 h / 0 °C
4: 56 percent / CF3COOH / various solvent(s) / 1.) -30 deg C, 2.) -20 deg C, 20 min, 3.) -10 deg C, 20 min
View Scheme

Cefoxitin History

Cefoxitin Specification

The Cefoxitin, with the CAS registry number 35607-66-0, has the IUPAC name of (6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid.

The characteristics of this chemical are as follows: (1)ACD/LogP: 0.63; (2)# of Rule of 5 Violations: 1 ; (3)#H bond acceptors: 10; (4)#H bond donors: 4; (5)#Freely Rotating Bonds: 8; (6)Polar Surface Area: 201.8; (7)Index of Refraction: 1.692; (8)Molar Refractivity: 100.47 cm3; (9)Molar Volume: 262.1 cm3; (10)Polarizability: 39.83 ×10-24 cm3; (11)Surface Tension: 86.7 dyne/cm; (12)Density: 1.63 g/cm3; (13)Flash Point: 463.9 °C; (14)Enthalpy of Vaporization: 128.44 kJ/mol; (15)Boiling Point: 843.4 °C at 760 mmHg; (16)Vapour Pressure: 3.24E-30 mmHg at 25°C; (17)Exact Mass: 427.050791; (18)MonoIsotopic Mass: 427.050791; (19)Topological Polar Surface Area: 202; (20)Heavy Atom Count: 28; (21)Complexity: 744.

In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3
(2)Isomeric SMILES: CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3
(3)InChI: InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1
(4)InChIKey: WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 

Below are the toxicity information of this chemical:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous > 10gm/kg (10000mg/kg)   Chemotherapy Vol. 26(Suppl1), Pg. 150, 1978.
mouse LD50 intravenous 4970mg/kg (4970mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Chemotherapy Vol. 26(Suppl,
mouse LD50 oral > 10gm/kg (10000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" Chemotherapy Vol. 26(Suppl1), Pg. 150, 1978.
mouse LD50 subcutaneous 9250mg/kg (9250mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Chemotherapy Vol. 26(Suppl,
rat LD50 intravenous 8580mg/kg (8580mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Chemotherapy Vol. 26(Suppl,
rat LD50 oral > 10gm/kg (10000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" Chemotherapy Vol. 26(Suppl1), Pg. 150, 1978.
rat LD50 subcutaneous > 10mg/kg (10mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Chemotherapy Vol. 26(Suppl,
women TDLo intravenous 75mg/kg/18H-I (75mg/kg) BLOOD: LEUKOPENIA Annals of Internal Medicine. Vol. 92, Pg. 874, 1980.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View